. . . . . . . . . . . "p(HGNC:CCND1) -> path(SDIS:\"Cisplatin resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "cyclin D1-overexpressing cells exhibited significantly reduced chemosensitivity and a higher survival rate upon cisplatin treatment. siRNA-directed suppression of cyclin D1 expression resulted in enhanced susceptibility to cisplatin-mediated apoptosis." . . "Selventa" . . . . "2014-07-03T14:30:37.712+02:00"^^ . . .